Ocunova Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Ocunova General Information
Description
Developer of a medical drug intended to be used to cure Dry Eye Syndrome. The company's therapy drug targets the specific type of dry eye that afflicts people with diabetes, enabling patients suffering from diabetes to restore normal tear secretions.
Contact Information
Website
www.ocunova.comCorporate Office
- 526 Park Ridge Drive Wayne
- Chester, PA 19087
- United States
Corporate Office
- 526 Park Ridge Drive Wayne
- Chester, PA 19087
- United States
Ocunova Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 28-Feb-2021 | Completed | Out of Business | |||
| 1. Seed Round | 21-Jan-2019 | Completed | Clinical Trials - Phase 2 |
Ocunova Signals
Ocunova FAQs
-
When was Ocunova founded?
Ocunova was founded in 2017.
-
Where is Ocunova headquartered?
Ocunova is headquartered in Chester, PA.
-
What is the size of Ocunova?
Ocunova has 4 total employees.
-
What industry is Ocunova in?
Ocunova’s primary industry is Drug Discovery.
-
Is Ocunova a private or public company?
Ocunova is a Private company.
-
What is Ocunova’s current revenue?
The current revenue for Ocunova is .
-
How much funding has Ocunova raised over time?
Ocunova has raised $600K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process